0,932  0,004  CYP1A2 substrate
0,925  0,002  UGT1A9 substrate
0,917  0,002  NOS2 expression inhibitor
0,907  0,004  TNF expression inhibitor
0,902  0,004  Chemoprotective
0,886  0,002  UGT1A3 substrate
0,869  0,003  UGT1A6 substrate
0,866  0,001  SULT1A3 substrate
0,856  0,003  Antimutagenic
0,856  0,004  Antioxidant
0,854  0,005  Caspase 9 stimulant
0,850  0,002  UGT1A1 substrate
0,849  0,003  Genotoxic
0,844  0,004  UDP-glucuronosyltransferase substrate
0,829  0,003  Skin whitener
0,828  0,004  Aldehyde oxidase inhibitor
0,818  0,004  Free radical scavenger
0,824  0,014  Apoptosis agonist
0,813  0,004  CYP2C19 substrate
0,805  0,006  Antihypercholesterolemic
0,796  0,003  Monophenol monooxygenase inhibitor
0,796  0,004  CTGF expression inhibitor
0,790  0,001  UGT2B15 substrate
0,790  0,004  Amyloid beta aggregation inhibitor
0,787  0,002  Cystathionine beta-synthase inhibitor
0,782  0,002  Melanin inhibitor
0,778  0,001  Creatine kinase inhibitor
0,779  0,004  Caspase 3 stimulant
0,762  0,007  Chemopreventive
0,770  0,019  Antiinflammatory
0,752  0,003  Amylase inhibitor
0,753  0,004  CYP1A2 inhibitor
0,736  0,004  Histamine release inhibitor
0,754  0,025  Alpha-glucosidase inhibitor
0,732  0,004  Sulfotransferase substrate
0,731  0,005  AR expression inhibitor
0,725  0,002  Estrogen receptor alpha antagonist
0,705  0,001  Histidine decarboxylase inhibitor
0,703  0,003  Estrogen receptor beta antagonist
0,710  0,019  Transcription factor NF kappa B inhibitor
0,692  0,003  Estrogen antagonist
0,701  0,013  15-Lipoxygenase inhibitor
0,701  0,020  Antineoplastic (breast cancer)
0,674  0,006  Lipoxygenase inhibitor
0,672  0,008  Proliferative diseases treatment
0,663  0,004  MAO inhibitor
0,652  0,005  Antiamyloidogenic
0,646  0,004  Peroxidase inhibitor
0,639  0,002  Antihemorrhagic
0,635  0,003  Beta glucuronidase inhibitor
0,634  0,003  Xanthine oxidase inhibitor
0,635  0,009  NOS3 expression inhibitor
0,643  0,020  Cyclophilin D inhibitor
0,643  0,020  Antidiabetic
0,646  0,023  CYP3A4 substrate
0,625  0,007  CYP2C19 inhibitor
0,622  0,008  Cardioprotectant
0,616  0,009  Nitric oxide antagonist
0,604  0,005  Antihypertriglyceridemic
0,607  0,008  Hypoglycemic
0,606  0,007  Hypoxia-inducible factor 1 alpha inhibitor
0,597  0,011  Hepatic disorders treatment
0,589  0,005  Antihypoxic
0,592  0,008  GABA C receptor rho-3 antagonist
0,593  0,010  Apoptosis antagonist
0,589  0,015  Mutagenic
0,589  0,018  Carcinogenic
0,575  0,007  Vascular (periferal) disease treatment
0,581  0,015  Spasmolytic
0,574  0,013  Antiosteoporotic
0,573  0,014  Cytostatic
0,554  0,005  MAO B inhibitor
0,562  0,012  Antineoplastic (brain cancer)
0,551  0,004  VCAM1 expression inhibitor
0,574  0,028  Alzheimer's disease treatment
0,548  0,004  Breast cancer-resistant protein inhibitor
0,548  0,005  Hepatoprotectant
0,546  0,004  5 Hydroxytryptamine uptake stimulant
0,563  0,022  Prostate cancer treatment
0,556  0,019  Bone diseases treatment
0,539  0,002  Estrogen receptor beta agonist
0,540  0,003  Estrogen agonist
0,538  0,004  Glutathione S-transferase substrate
0,548  0,019  Sensitization
0,519  0,003  Aromatase inhibitor
0,529  0,013  Antipyretic
0,521  0,005  NOS3 expression enhancer
0,544  0,029  Antineoplastic (colorectal cancer)
0,516  0,004  Neurotrophic factor enhancer
0,512  0,004  UGT2B1 substrate
0,516  0,011  Vasodilator
0,538  0,033  Antileukemic
0,526  0,025  Respiratory analeptic
0,514  0,017  Antineoplastic (glioma)
0,524  0,030  Antineoplastic (colon cancer)
0,515  0,022  CYP2C9 inhibitor
0,525  0,034  Antibacterial
0,513  0,023  Cytotoxic
0,501  0,014  Tumour necrosis factor alpha release inhibitor
0,507  0,021  Antineoplastic (cervical cancer)
0,489  0,004  Antitussive
0,484  0,005  Acetylcholinesterase inhibitor
0,484  0,005  Lipid peroxidase inhibitor
0,486  0,012  Antineoplastic enhancer
0,515  0,043  Antineoplastic (lung cancer)
0,472  0,005  GST M1-1 substrate
0,489  0,024  Analeptic
0,468  0,003  Carbonic anhydrase III inhibitor
0,476  0,015  UGT2B4 substrate
0,466  0,005  Pneumotoxic
0,492  0,033  Teratogen
0,459  0,003  NAD(P)H dehydrogenase (quinone) inhibitor
0,477  0,024  12-Lipoxygenase inhibitor
0,451  0,011  UGT1A4 substrate
0,446  0,008  Antihypotensive
0,455  0,022  ICAM1 expression inhibitor
0,445  0,018  Antidiabetic symptomatic
0,441  0,021  Antineoplastic (glioblastoma multiforme)
0,459  0,045  CYP2C9 substrate
0,443  0,033  Antifungal
0,422  0,014  P-glycoprotein inhibitor
0,415  0,009  Cholinergic
0,425  0,022  Antiparasitic
0,410  0,008  Protein-tyrosine phosphatase inhibitor
0,450  0,049  Antipruritic, allergic
0,407  0,010  Topoisomerase II inhibitor
0,435  0,038  Embryotoxic
0,401  0,004  Cholesterol synthesis inhibitor
0,430  0,035  Antineoplastic (melanoma)
0,409  0,017  RNA-directed DNA polymerase inhibitor
0,400  0,009  MAO A inhibitor
0,446  0,057  Antiparkinsonian
0,408  0,020  Myocardial infarction treatment
0,392  0,005  Expectorant
0,397  0,012  UGT2B7 substrate
0,398  0,017  Antihelmintic
0,424  0,048  Ulceration
0,403  0,029  Antiprotozoal (Leishmania)
0,376  0,004  Postmenopausal disorders treatment
0,431  0,061  5 Hydroxytryptamine release inhibitor
0,412  0,043  5 Hydroxytryptamine release stimulant
0,372  0,004  Nitric-oxide synthase stimulant
0,378  0,010  Protein kinase stimulant
0,396  0,029  DNA damaging
0,404  0,037  Antineoplastic (pancreatic cancer)
0,372  0,005  NADPH oxidase inhibitor
0,371  0,006  Protein-tyrosine phosphatase 1B inhibitor
0,369  0,005  Carbonic anhydrase XV inhibitor
0,380  0,018  Antineoplastic (sarcoma)
0,400  0,039  Radioprotector
0,362  0,004  Gastritis treatment
0,383  0,025  Antineoplastic (osteosarcoma)
0,362  0,007  M18 aspartyl aminopeptidase inhibitor
0,389  0,035  Antineoplastic (non-small cell lung cancer)
0,399  0,044  Antineoplastic (ovarian cancer)
0,383  0,033  Cardiovascular analeptic
0,355  0,005  Topoisomerase II alpha inhibitor
0,392  0,045  CYP2D6 substrate
0,349  0,005  Carbonic anhydrase VI inhibitor
0,348  0,004  Mucolytic
0,399  0,057  Stroke treatment
0,344  0,003  Estrogen receptor alpha agonist
0,346  0,007  5-Lipoxygenase inhibitor
0,342  0,004  VEGF expression inhibitor
0,349  0,021  Dual specificity phosphatase 3 inhibitor
0,349  0,021  Dual specificity phosphatase inhibitor
0,334  0,007  Interleukin 4 antagonist
0,335  0,008  Alkaline phosphatase inhibitor
0,395  0,069  GST A substrate
0,357  0,032  Antineoplastic (liver cancer)
0,344  0,021  Platelet adhesion inhibitor
0,327  0,004  SULT1A1 substrate
0,334  0,012  Antidote
0,338  0,017  Antineoplastic (squamous cell carcinoma)
0,349  0,030  Antiulcerative
0,348  0,033  Antimitotic
0,318  0,003  Carbonic anhydrase VII inhibitor
0,316  0,006  Dementia treatment
0,311  0,006  Vascular dementia treatment
0,322  0,018  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,320  0,025  Antiviral (Influenza)
0,303  0,010  UGT2B9 substrate
0,311  0,018  Tubulin antagonist
0,305  0,013  Antidiarrheal
0,294  0,003  Estradiol 17 beta-dehydrogenase inhibitor
0,301  0,011  Chelator
0,301  0,013  Alkylator
0,291  0,004  Antiviral (SARS coronavirus)
0,291  0,004  Antiviral (Coronavirus)
0,329  0,042  Superoxide dismutase inhibitor
0,303  0,016  Diabetic nephropathy treatment
0,299  0,014  Cyclooxygenase 1 inhibitor
0,292  0,007  Androgen antagonist
0,318  0,035  Cyclic AMP phosphodiesterase inhibitor
0,315  0,039  Psychostimulant
0,278  0,012  LDLR expression enhancer
0,270  0,003  DOPA decarboxylase inhibitor
0,269  0,004  Multidrug resistance-associated protein 1 inhibitor
0,307  0,052  Transcription factor STAT inhibitor
0,327  0,073  Antithrombotic
0,257  0,004  Xanthine dehydrogenase inhibitor
0,271  0,019  Interleukin 6 antagonist
0,271  0,021  Liver fibrosis treatment
0,267  0,017  Succinate dehydrogenase inhibitor
0,252  0,005  Antineoplastic (uterine cancer)
0,262  0,015  Topoisomerase I inhibitor
0,251  0,005  Aldose reductase inhibitor
0,261  0,015  Antiprotozoal (Coccidial)
0,319  0,073  Vasodilator, coronary
0,253  0,011  GABA C receptor rho-2 antagonist
0,246  0,004  SULT1E1 substrate
0,284  0,042  Tyrosine 3 hydroxylase inhibitor
0,249  0,009  Carbonic anhydrase XIII inhibitor
0,306  0,066  Lipoprotein disorders treatment
0,238  0,004  Ca(v)3.2 blocker
0,239  0,005  Papain-like protease (SARS coronavirus) inhibitor
0,253  0,020  Heat shock protein 90 antagonist
0,249  0,017  DNA polymerase I inhibitor
0,328  0,098  Immunosuppressant
0,283  0,056  Angiogenesis stimulant
0,245  0,019  Antifungal enhancer
0,234  0,007  Antihelmintic (Trematoda)
0,233  0,008  AMP-activated protein kinase stimulant
0,328  0,104  Atherosclerosis treatment
0,301  0,078  CYP3A4 inhibitor
0,251  0,034  Antipruritic, non-allergic
0,250  0,034  Insulin sensitizer
0,245  0,029  Interferon gamma antagonist
0,219  0,004  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,226  0,012  Cyclooxygenase 3 inhibitor
0,284  0,070  Antineurogenic pain
0,221  0,008  HIV-1 integrase (3'-Processing) inhibitor
0,250  0,037  CYP2B6 inhibitor
0,294  0,082  Streptokinase A inhibitor
0,216  0,004  Ornithine decarboxylase inhibitor
0,220  0,010  Uric acid excretion stimulant
0,252  0,044  Antialcoholic
0,217  0,009  Opioid kappa receptor antagonist
0,254  0,045  DNA methyltransferase I inhibitor
0,279  0,073  Antidiabetic (type 2)
0,210  0,009  Antiviral (Influenza B)
0,292  0,092  FMO1 substrate
0,205  0,006  Alpha tubulin antagonist
0,258  0,059  Interleukin antagonist
0,202  0,003  Estradiol 17 beta-dehydrogenase 1 inhibitor
0,269  0,070  Transcription factor STAT3 inhibitor
0,263  0,065  Gastrin inhibitor
0,232  0,035  Antineoplastic (carcinoma)
0,218  0,021  Gout treatment
0,235  0,039  Amyloid beta precursor protein antagonist
0,215  0,018  Carcinogenic, group 2B
0,265  0,070  Antineoplastic (renal cancer)
0,231  0,038  Antihelmintic (Nematodes)
0,197  0,004  Ca(v)3.1 blocker
0,218  0,025  UGT2B10 substrate
0,225  0,033  Antiviral (Influenza A)
0,203  0,012  HDL-cholesterol increasing
0,277  0,088  Antiischemic
0,208  0,020  Butyrylcholinesterase inhibitor
0,230  0,043  Mcl-1 antagonist
0,193  0,006  Lipase inhibitor
0,224  0,039  Antiviral (Herpes)
0,189  0,004  Fatty acid synthase inhibitor
0,218  0,035  Cyclooxygenase inhibitor
0,202  0,021  Antineoplastic antibiotic
0,216  0,035  Phospholipase A2 inhibitor
0,233  0,054  Abortion inducer
0,200  0,022  CF transmembrane conductance regulator agonist
0,192  0,014  GABA C receptor antagonist
0,184  0,009  Macrophage migration inhibitory factor inhibitor
0,210  0,035  Carcinogenic, group 3
0,251  0,078  Antineoplastic (bladder cancer)
0,239  0,073  Cardiodepressant
0,194  0,029  Aldehyde dehydrogenase inhibitor
0,176  0,012  Electron transport complex I inhibitor
0,203  0,040  Toxic, respiratory center
0,261  0,100  Antimycobacterial
0,197  0,036  Arachidonic acid antagonist
0,174  0,013  GABA C receptor rho-1 antagonist
0,272  0,111  Antineoplastic (small cell lung cancer)
0,224  0,064  DNA methylase inhibitor
0,183  0,024  Microtubule formation inhibitor
0,255  0,097  FMO3 substrate
0,195  0,039  Antiseptic
0,186  0,030  Proteasome inhibitor
0,164  0,012  HIV-1 integrase (Strand Transfer) inhibitor
0,155  0,005  Antiviral (Hepatitis A)
0,185  0,037  Cell wall synthesis inhibitor
0,153  0,005  Neuraminidase inhibitor
0,194  0,046  Antirickettsial
0,164  0,017  Urease inhibitor
0,215  0,073  Pyruvate kinase inhibitor
0,147  0,006  Opioid kappa receptor agonist
0,261  0,119  Vasodilator, peripheral
0,154  0,014  Paget's disease treatment
0,195  0,056  Antineoplastic (gastric cancer)
0,153  0,014  UGT2B11 substrate
0,157  0,018  Protein kinase C zeta inhibitor
0,157  0,019  Alcohol dehydrogenase inhibitor
0,162  0,026  Contraceptive female
0,156  0,020  Prolactin inhibitor
0,158  0,023  Opioid antagonist
0,235  0,101  Antituberculosic
0,218  0,084  MAP-kinase-activated kinase 5 inhibitor
0,296  0,163  DNA directed DNA polymerase inhibitor
0,169  0,036  Adenylate cyclase stimulant
0,173  0,041  Cyclooxygenase 2 inhibitor
0,191  0,059  Tumour necrosis factor antagonist
0,147  0,015  Keratolytic
0,229  0,097  Antiprotozoal (Trypanosoma)
0,162  0,032  Beta amyloid protein antagonist
0,158  0,031  Heat shock protein 70 antagonist
0,146  0,020  Anabolic
0,154  0,029  Photosensitizer
0,147  0,022  Toll-Like receptor 4 antagonist
0,183  0,060  Heat shock protein 90 alpha antagonist
0,227  0,106  Immunostimulant
0,246  0,126  Angiogenesis inhibitor
0,188  0,069  Antiviral (Hepatitis)
0,128  0,010  D-Ala-D-Ala ligase inhibitor
0,140  0,024  Actinic keratosis treatment
0,126  0,010  Neuraminidase (influenza) inhibitor
0,147  0,033  Constipation treatment
0,191  0,078  Non-steroidal antiinflammatory agent
0,116  0,004  Postcoital contraceptive
0,143  0,034  Bronchodilator
0,177  0,067  Antipruritic
0,151  0,041  Ca2+-transporting ATPase inhibitor
0,217  0,108  Flavin-containing monooxygenase substrate
0,166  0,059  Insulin secretagoues
0,111  0,004  Transcription factor RelA inhibitor
0,166  0,060  Hair growth stimulant
0,125  0,020  Carbonic anhydrase V inhibitor
0,154  0,050  Toll-Like receptor 2 antagonist
0,117  0,014  Narcotic antagonist
0,118  0,014  SULT1A2 substrate
0,156  0,054  Bone formation stimulant
0,121  0,019  Dopamine D1 antagonist
0,119  0,018  Beta tubulin antagonist
0,117  0,016  HIV-1 integrase inhibitor
0,278  0,177  DNA polymerase beta inhibitor
0,119  0,018  Carbonic anhydrase VA inhibitor
0,153  0,053  Psychosexual dysfunction treatment
0,257  0,157  Antiprotozoal
0,124  0,025  Interleukin 12 antagonist
0,112  0,014  Carbonic anhydrase VB inhibitor
0,136  0,039  GST P1-1 substrate
0,172  0,074  Antineoplastic (bone cancer)
0,156  0,060  Contraceptive
0,131  0,035  Protein kinase C mu inhibitor
0,109  0,015  Protein kinase C eta inhibitor
0,135  0,041  Choleretic
0,115  0,022  Glutamate decarboxylase inhibitor
0,110  0,018  Leukotriene antagonist
0,116  0,024  Analgesic, opioid
0,192  0,100  Hypolipemic
0,184  0,092  Antiviral (Ebola)
0,097  0,007  Glucose-6-phosphate translocase inhibitor
0,103  0,015  Antidote, heavy metal
0,158  0,071  Carcinogenic, group 1
0,271  0,184  Calcium channel L-type activator
0,123  0,038  HIV-1 integrase (Overall Integration) inhibitor
0,149  0,065  Mannose-6-phosphate isomerase inhibitor
0,108  0,025  Cyclin B3 inhibitor
0,106  0,025  Dopamine agonist
0,108  0,028  Opioid delta receptor antagonist
0,105  0,027  Na+ K+ transporting ATPase inhibitor
0,092  0,015  Opioid agonist
0,208  0,131  Radiosensitizer
0,129  0,052  DNA intercalator
0,161  0,085  Phospholipase C inhibitor
0,090  0,015  SULT2A1 substrate
0,131  0,058  Coagulant
0,118  0,045  UDP-glucose 4-epimerase inhibitor
0,151  0,078  Eye irritation, high
0,178  0,107  Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor
0,129  0,059  Growth stimulant
0,078  0,009  Sodium/calcium exchanger inhibitor
0,075  0,007  Dopamine D5 agonist
0,099  0,032  Opioid mu receptor antagonist
0,100  0,033  Telomerase inhibitor
0,137  0,071  Farnesoid X receptor antagonist
0,107  0,041  Phosphodiesterase 6D inhibitor
0,179  0,114  Antineoplastic (lymphoma)
0,119  0,053  Protein kinase C gamma inhibitor
0,096  0,031  Histone deacetylase SIRT1 stimulant
0,096  0,031  Histone deacetylase stimulant
0,067  0,004  Estrogen-related receptor beta antagonist
0,100  0,037  Phosphodiesterase 4D inhibitor
0,070  0,008  Arginase inhibitor
0,106  0,043  ABCA1 expression enhancer
0,180  0,117  Platelet antagonist
0,142  0,079  Antiischemic, cerebral
0,163  0,102  Antiarrhythmic
0,150  0,089  Antiviral (Hepatitis C)
0,213  0,153  Cholesterol antagonist
0,076  0,017  Leukotriene B4 antagonist
0,140  0,081  Hemostatic
0,147  0,090  Uterine stimulant
0,099  0,043  Interleukin 5 antagonist
0,090  0,034  CDC25A inhibitor
0,069  0,014  Squalene epoxidase inhibitor
0,086  0,032  MAP kinase kinase 7 inhibitor
0,218  0,164  Sodium/bile acid cotransporter inhibitor
0,126  0,073  Antibacterial (Helicobacter pylori)
0,107  0,055  Chronic obstructive bronchitis treatment
0,109  0,056  GST T1-1 substrate
0,057  0,005  ATP citrate lysase inhibitor
0,141  0,089  Thrombolytic
0,090  0,039  Antibiotic
0,083  0,033  Glucagon-like peptide 1 agonist
0,071  0,021  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,109  0,059  Mediator release inhibitor
0,084  0,035  Leukotriene synthesis inhibitor
0,067  0,018  Topoisomerase II beta inhibitor
0,124  0,074  Antihyperlipoproteinemic
0,082  0,033  Secretase beta inhibitor
0,090  0,041  Thioredoxin reductase inhibitor
0,060  0,011  Estradiol 17 beta-dehydrogenase 2 inhibitor
0,060  0,013  Neuraminidase (Influenza A) inhibitor
0,065  0,019  Dopamine D2 agonist
0,057  0,012  Retinoid X alpha receptor agonist
0,155  0,110  Antieczematic atopic
0,053  0,008  Cholesterol absorption inhibitor
0,051  0,006  Sodium/glucose cotransporter 2 inhibitor
0,139  0,094  Neuropathy treatment
0,053  0,008  Catechol O-methyltransferase inhibitor
0,110  0,066  Endometrios treatment
0,065  0,021  Opioid mu receptor agonist
0,091  0,047  Myeloperoxidase inhibitor
0,072  0,028  Alcohol oxidase inhibitor
0,120  0,077  Alpha-N-acetylglucosaminidase inhibitor
0,177  0,134  Peptidyltransferase inhibitor
0,139  0,097  Prostatic (benign) hyperplasia treatment
0,078  0,036  Anticholelithogenic
0,093  0,052  NADH dehydrogenase inhibitor
0,081  0,039  Antitreponemal
0,075  0,034  Glutamate (mGluR7) antagonist
0,095  0,055  Thioredoxin inhibitor
0,164  0,125  Aryl hydrocarbon receptor agonist
0,044  0,006  Sodium/glucose cotransporter inhibitor
0,043  0,005  Dopamine D1 agonist
0,047  0,009  Tubulin agonist
0,049  0,012  Glucose-6-phosphate dehydrogenase inhibitor
0,200  0,164  Antiallergic
0,139  0,104  Cystic fibrosis treatment
0,055  0,022  Carbonic anhydrase IV inhibitor
0,134  0,101  MAP kinase kinase 4 inhibitor
0,111  0,078  Transcription factor STAT6 inhibitor
0,038  0,006  Sodium/glucose cotransporter 1 inhibitor
0,055  0,023  Cholesterol esterase inhibitor
0,137  0,107  Prostate disorders treatment
0,064  0,035  Heat shock protein 90 beta antagonist
0,055  0,027  Antibiotic Glycopeptide-like
0,072  0,044  Protein kinase C beta inhibitor
0,047  0,019  Retinoid X receptor agonist
0,113  0,088  Proto-oncogene tyrosine-protein kinase Yes inhibitor
0,107  0,085  Antiviral (Hepatitis B)
0,058  0,036  Acetyl-CoA transferase 2 inhibitor
0,070  0,049  Peroxisome proliferator-activated receptor gamma agonist
0,158  0,136  Antineoplastic (lymphocytic leukemia)
0,031  0,010  Estrone sulfatase inhibitor
0,155  0,137  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,044  0,028  Leukocyte elastase inhibitor
0,083  0,067  Granulocyte macrophage colony stimulating factor agonist
0,093  0,077  Skin irritative effect
0,176  0,160  DNA synthesis inhibitor
0,078  0,064  Antispirochetal
0,056  0,041  Leukotriene C antagonist
0,079  0,064  Inducible nitric-oxide synthase inhibitor
0,079  0,064  Carcinogenic, group 2A
0,087  0,073  Antiviral (Rhinovirus)
0,111  0,099  Cocaine dependence treatment
0,056  0,044  Lipocortins synthesis agonist
0,064  0,052  Phosphofructokinase-1 inhibitor
0,104  0,093  Shock treatment
0,035  0,025  Progesterone antagonist
0,148  0,138  Dyrk kinase inhibitor
0,045  0,035  Microtubule stabilization
0,079  0,070  Estrogen-related receptor beta agonist
0,049  0,039  Carbonic anhydrase XII inhibitor
0,031  0,023  Glucocorticoid antagonist
0,046  0,038  Carbonic anhydrase XIV inhibitor
0,140  0,132  Death-associated protein kinase 2 inhibitor
0,108  0,101  DNA repair enzyme inhibitor
0,113  0,106  Vanilloid 1 agonist
0,139  0,133  Neurotensin receptor agonist
0,120  0,114  MAP3K9 inhibitor
0,023  0,018  Protein 30S ribosomal subunit inhibitor
0,064  0,059  MDM2 inhibitor
0,058  0,054  Heme oxygenase stimulant
0,056  0,052  Transcription factor AP-1 inhibitor
0,033  0,030  5-Alpha-reductase inhibitor
0,032  0,030  Opioid delta receptor agonist
0,053  0,051  Androgen agonist
0,056  0,054  Antimycoplasmal
0,074  0,072  Glutathione S-transferase inhibitor

